Literature DB >> 19871251

THE IMMUNIZATION OF FOWLS AGAINST MOSQUITO-BORNE PLASMODIUM GALLINACEUM BY INJECTIONS OF SERUM AND OF INACTIVATED HOMOLOGOUS SPOROZOITES.

P F Russell1, B N Mohan.   

Abstract

This paper reports attempts to immunize domestic fowls against mosquito-borne infections of Plasmodium gallinaceum by means of (a) vaccination with inactivated homologous sporozoites; (b) injections of sera, both normal sheep serum, and serum from fowls chronically infected with the homologous Plasmodium, (c) combinations of both sporozoite vaccine and serum. It was possible to reduce the normal malaria death rate (55.4 per cent) in these fowls by each of the above methods but most markedly by the combined prophylactic treatment. Mortality rates were 21.1 per cent in vaccinated fowls, 16.7 per cent in serum-treated fowls, and 7.3 in those having the combined treatment. Intensity of infection was measured by counting the percentage of red cells infected each day. It was found that in each group of fowls having prophylactic treatment the average of highest percentages of red cells infected was less than in untreated malarious fowls (30.1 per cent). The average figure was 20.5 per cent in vaccinated fowls, 17.9 per cent in those having serum injections, and 15.0 per cent in those having combined treatment. The prepatent period was not markedly affected by any of the prophylactic procedures. It averaged 9.1 days in the untreated group, 8.9 days in both the vaccinated and serum-treated groups, and 9.7 days in the group having combined treatment. The results seemed to demonstrate an interaction of both cellular and humoral agencies in defence against malaria, since the greatest immunizing effect was seen in the series having both sporozoite vaccine and serum injections.

Entities:  

Year:  1942        PMID: 19871251      PMCID: PMC2135232          DOI: 10.1084/jem.76.5.477

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  DEMONSTRATION OF PASSIVE IMMUNITY IN EXPERIMENTAL MONKEY MALARIA.

Authors:  L T Coggeshall; H W Kumm
Journal:  J Exp Med       Date:  1937-07-31       Impact factor: 14.307

2.  PASSIVE IMMUNITY IN AVIAN MALARIA.

Authors:  R D Manwell; F Goldstein
Journal:  J Exp Med       Date:  1940-02-29       Impact factor: 14.307

  2 in total
  13 in total

Review 1.  Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond.

Authors:  Jerome P Vanderberg
Journal:  Vaccine       Date:  2008-10-28       Impact factor: 3.641

2.  New medicines for malaria.

Authors:  Benjamin Mordmüller
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

Review 3.  Acquired immunity to malaria.

Authors:  Denise L Doolan; Carlota Dobaño; J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 4.  Vaccines against malaria.

Authors:  Adrian V S Hill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

Review 5.  Application of radiation technology in vaccines development.

Authors:  Ho Seong Seo
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

Review 6.  Designing malaria vaccines to circumvent antigen variability.

Authors:  Amed Ouattara; Alyssa E Barry; Sheetij Dutta; Edmond J Remarque; James G Beeson; Christopher V Plowe
Journal:  Vaccine       Date:  2015-11-01       Impact factor: 3.641

Review 7.  Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.

Authors:  Thomas L Richie; Peter F Billingsley; B Kim Lee Sim; Eric R James; Sumana Chakravarty; Judith E Epstein; Kirsten E Lyke; Benjamin Mordmüller; Pedro Alonso; Patrick E Duffy; Ogobara K Doumbo; Robert W Sauerwein; Marcel Tanner; Salim Abdulla; Peter G Kremsner; Robert A Seder; Stephen L Hoffman
Journal:  Vaccine       Date:  2015-11-27       Impact factor: 3.641

8.  Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.

Authors:  Carly M Bliss; Georgina Bowyer; Nicholas A Anagnostou; Tom Havelock; Claudia M Snudden; Huw Davies; Simone C de Cassan; Amy Grobbelaar; Alison M Lawrie; Navin Venkatraman; Ian D Poulton; Rachel Roberts; Pooja B Mange; Prateek Choudhary; Saul N Faust; Stefano Colloca; Sarah C Gilbert; Alfredo Nicosia; Adrian V S Hill; Katie J Ewer
Journal:  Sci Rep       Date:  2018-02-21       Impact factor: 4.379

9.  FACTORS IN PLASMA CONCERNED IN NATURAL RESISTANCE TO AN AVIAN MALARIA PARASITE (PLASMODIUM LOPHURAE).

Authors:  W Trager; R B McGhee
Journal:  J Exp Med       Date:  1950-03-31       Impact factor: 14.307

Review 10.  Malaria vaccines: identifying Plasmodium falciparum liver-stage targets.

Authors:  Rhea J Longley; Adrian V S Hill; Alexandra J Spencer
Journal:  Front Microbiol       Date:  2015-09-15       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.